Aditxt Announces Partnership Agreements with Appili Therapeutics and Evofem Biosciences
08/29/24, 12:27 PM
Location
Industry
health care
Type
partnership
Aditxt, Inc. announced its partnership agreements with Appili Therapeutics, Inc. and Evofem Biosciences, Inc. at the H.C
Company Info
Location
737 n. fifth street
richmond, california, united states
Additional Info
Aditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. Aditxt’s immune monitoring technology is designed to provide a personalized comprehensive profile of the immune system. Aditxt’s immune reprogramming technology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. For more information, please visit: www.aditxt.com